Rehabilitación respiratoria en pacientes con fibrosis quística: revisión sistemática

Jonathan Alexander  Nuñez Ibarra; Paola Gabriela  Ortiz Villalba; Stalin Javier  Caiza Lema; Jonathan Javier   Yansapanta Yugcha

doi:10.51736/sa.v7iEspecial 3.285

Authors

Jonathan Alexander Nuñez Ibarra Technical University of Ambato, Ecuador https://orcid.org/0009-0002-8893-9065
Paola Gabriela Ortiz Villalba Professor at the Technical University of Ambato, Ecuador. https://orcid.org/0000-0001-6810-8841
Stalin Javier Caiza Lema Professor at the Technical University of Ambato, Ecuador. https://orcid.org/0000-0003-2393-3885
Jonathan Javier Yansapanta Yugcha Professor at the Technical University of Ambato, Ecuador. https://orcid.org/0009-0004-1072-6144

DOI:

https://doi.org/10.51736/sa.v7iEspecial%203.285

Keywords:

cystic fibrosis, respiratory therapy, physiotherapy, exercise

Abstract

Cystic fibrosis (CF) is a genetic disease that affects predominantly Caucasians according to ethnic and geographical groups. This disease is caused by the CFTR gene, which is responsible for ion transport; when dysfunctional, it generates mucous secretions at the pulmonary level. In the context of physiotherapy, it helps improve pulmonary secretions and lung capacity. The objective of this review article is to evaluate the efficacy of respiratory rehabilitation in patients diagnosed with CF, analyzing existing literature to identify the most effective interventions in improving lung function. A search for information from the last 5 years was conducted in databases such as PubMed, Google Scholar, Scielo, Elsevier, and Springer with MeSH terms. Studies in English or Spanish were identified, and those that were controlled or randomized trials were considered. Inclusion and exclusion criteria were applied, and 13 articles addressing techniques and exercises in CF patients were selected. The PRISMA model was employed. Thirteen articles were included in this review, including exercises, techniques, electrotherapy, resistance training, aerobic training and nebulizer therapies. In which a positive trend was observed in most of the articles, showing benefits in the CF patient. The application of different techniques proved to be a very important component at the time of performing and treating the patient with CF. Both aerobic and resistance exercise combined with different instruments helped to improve lung capacity and the elimination of secretions.

Downloads

Download data is not yet available.

References

Burnham P., Stanford, G., Stewart, R. (2021). Autogenic drainage for airway clearance in cystic fibrosis. Cochrane Database of Systematic Reviews.

Dentice, R. L., Elkins, M. R., Verschuer, J., Eberl, S., Dwyer, G., Bye, P.T.P. (2019). Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: A randomised crossover trial. BMC Pulm Med, 19(1).

Donadio, M. V. F., Cobo-Vicente, F., San Juan, A.F., Sanz-Santiago, V., Fernández-Luna, Á., Iturriaga, T. (2022). Is exercise and electrostimulation effective in improving muscle strength and cardiorespiratory fitness in children with cystic fibrosis and mild-to-moderate pulmonary impairment?: Randomized controlled trial. Respir Med, 196.

Dwyer, T.J., Daviskas, E., Zainuldin, R., Verschuer, J., Eberl. S., & Bye, P.T.P. (2019). Effects of exercise and airway clearance (positive expiratory pressure) on mucus clearance in cystic fibrosis: A randomised crossover trial. European Respiratory Journal, 53(4).

Emirza, C., Aslan, G. K., Kilinc, A. A., Cokugras, H. (2021). Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis: A randomized controlled trial. Pediatr Pulmonol, 56(5).

García-Pérez, G., Yvert, T., Blanco, Á., Sosa, A. I., Thuissard, I. J., Pérez-Ruiz, M. (2022). Effectiveness of Physical Exercise Interventions on Pulmonary Function and Physical Fitness in Children and Adults with Cystic Fibrosis: A Systematic Review with Meta-Analysis. Healthcare (Switzerland), 10.

Gursli, S., Quittner, A., Jahnsen, R. B., Skrede, B., Stuge, B., Bakkeheim, E. (2022). Airway clearance physiotherapy and health-related quality of life in cystic fibrosis. PLoS One,17.

Heijerman, H. G. M., McKone, E. F., Downey, D.G., Van Braeckel, E., Rowe, S. M., & Tullis, E. (2019). Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. The Lancet, 394(10212).

Kaltsakas, G., Chynkiamis, N., Anastasopoulos, N., Zeliou, P., Karapatoucha, V., & Kotsifas, K. (2021). Interval versus constant-load exercise training in adults with Cystic Fibrosis. Respir Physiol Neurobiol. 288.

Karanth, T. K., Karanth, V., & Ward, B. K., (2022). Woodworth BA, Karanth L. Medical interventions for chronic rhinosinusitis in cystic fibrosis. Cochrane Database of Systematic Reviews

McIlwaine, M., Button, B., & Nevitt, S. J. (2019). Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews.

Mall, M. A., Brugha, R., Gartner, S., Legg, J., Moeller, A., & Mondejar-Lopez, P. Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation A Phase 3b, Randomized, Placebo-controlled Study. Am J Respir Crit Care Med., 206(11).

Moseley, A. M., Elkins, M.R., Van der Wees, P. J., & Pinheiro, M. B. (2020). Using research to guide practice: The Physiotherapy Evidence Database (PEDro). Brazilian Journal of Physical Therapy, 24.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T.C, & Mulrow, C.D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ, 372.

Radtke, T., Böni, L., Bohnacker, P., Maggi-Beba, M., Fischer, P., & Kriemler, S., Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: A randomized, controlled, crossover trial. BMC Pulm Med, 18(1).

San Miguel-Pagola, M., Reychler, G., Cebrià, I., Iranzo, M. A., Gómez-Romero, M., Díaz-Gutiérrez, F., & Herrero-Cortina, B. (2020). Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial. Physiotherapy, 107.

Smith, S., Rowbotham, N. J., & Edwards, C.T. (2022). Short-acting inhaled bronchodilators for cystic fibrosis. Cochrane Database of Systematic Reviews

Sosa-Pedreschi, A., Donadio, M. V. F., Iturriaga-Ramírez, T., Yvert, T., Pérez-Salazar, F., Santiago-Dorrego, C. (2024). Effects of a remotely supervised resistance training program on muscle strength and body composition in adults with cystic fibrosis: Randomized controlled trial. Scand J Med Sci Sports, 34(1).

Spoletini, G., Watson, R., Lim, W. Y., Pollard, K., Etherington, C., Clifton, I. J. (2021). Nasal high-flow therapy as an adjunct to exercise in patients with cystic fibrosis: A pilot feasibility trial. Journal of Cystic Fibrosis, 20(5).

Wilson, J., You, X., Ellis, M., Urquhart, D. S., Jha, L., Duncan, M. (2021), VO2max as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trial. Journal of Cystic Fibrosis, 20(3).

Zeren, M., Cakir, E., & Gurses, H. N. (2019). Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: A randomised controlled trial. Respir Med, 148.